Key account manager senior Settore Farmaceutico
Pubblicato il 30-08-2026 - Genmab in Italia
At Genmab, we are dedicated to building extra[not]ordinary® futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines® that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.
Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.
As pioneers in antibody biology and innovation, are seeking a driven and talented individual to help deliver our cutting-edge oncology treatments to patients across Italy. If you’re passionate about oncology, bring experience from both large pharmaceutical organizations and nimble biotech environments, and want to be part of an ambitious team,
we want to hear from you
The Oncology Key Account Manager will play a pivotal role in establishing Genmab in Italy with accountability for building and maintaining strong relationships with key stakeholders, including hospitals, specialist cancer centers, academic medical institutions, and oncology professionals across Italy. This individual will be responsible for promoting Genmab’s oncology portfolio, with a focus on solid tumors and gynecologic oncology, to healthcare professionals and key decision-makers.
The KAM will be responsible for driving product adoption and ensuring optimal regional and local access across assigned territories. The role requires a strong blend of scientific engagement, account management, stakeholder partnership, and market access capabilities. The successful candidate will work cross-functionally to identify opportunities, remove barriers to access, and deliver value to healthcar